Health ❯ Healthcare ❯ Pharmaceuticals ❯ Drug Regulation

FDA Oversight

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

The warning focuses on mass-marketed 'personalized' versions sold outside FDA review.

TrumpRx Launches, Offering Discounted Brand‑Name Drugs Through U.S. Portal